Formula: | C20H22N4O5S |
Molecular Weight: | 430.49 |
Rotatable Bond Donors: | 5 |
clogP: | 2.56 |
Topological Polar Surface Area: | 117.53 |
Lipinski's RO5: | MW: 430.49 HBA: 9 HBD: 2 RB: 5 LogP: 2.56 |
Rule of Three: | MW: 430.49 HBA: 9 HBD: 2 RB: 5 LogP: 2.56 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS24700 | 0.72 | EOS24700 RDKit 3D 27 29 0 0 0 0 0 0 0 0999 V2000 7.7138 3.0331 0.1441 C 0 0 0 0 0 0 0 0 0 0 0 0 6.8484 2.9434 -0.9820 O 0 0 0 0 0 0 0 0 0 0 0 0 5.6878 2.2925 -0.6689 C 0 0 0 0 0 0 0 0 0 0 0 0 5.3868 1.7862 0.5948 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1746 1.1367 0.8185 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2570 0.9897 -0.2200 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0597 0.3274 0.0751 N 0 0 0 0 0 0 0 0 0 0 0 0 1.0143 0.0674 -0.7942 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9918 0.3898 -1.9790 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.0838 -0.6389 -0.1604 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1128 -0.9939 1.1605 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.2693 -1.6336 1.4844 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5114 -2.1082 2.8591 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0330 -1.7052 0.3328 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6264 -2.3902 0.1830 S 0 0 0 0 0 0 0 0 0 0 0 0 -3.7027 -2.8406 -1.1897 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.7351 -3.3106 1.2951 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.7728 -1.1700 0.4027 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.7924 -0.1417 -0.6523 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3872 1.2380 -0.1556 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4555 1.1553 0.9165 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1105 0.6107 2.0552 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.8940 -0.6672 1.7803 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2817 -1.0825 -0.7137 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6917 -0.9282 -2.1293 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5570 1.4953 -1.4827 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7691 2.1451 -1.7066 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 1 0 8 9 2 0 8 10 1 0 10 11 1 0 11 12 1 0 12 13 1 0 12 14 2 0 14 15 1 0 15 16 2 0 15 17 2 0 15 18 1 0 18 19 1 0 19 20 1 0 20 21 1 0 21 22 1 0 22 23 1 0 14 24 1 0 24 25 1 0 6 26 1 0 26 27 2 0 27 3 1 0 24 10 2 0 23 18 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |